MyFinsight
Home
Blog
About
Short-term investments
$263,291K
(0.44%↑ Y/Y)
Cash, cash
equivalents and restricted...
$179,832K
(239.29%↑ Y/Y)
Inventory
$45,151K
(-2.91%↓ Y/Y)
Accounts receivable, net
$41,138K
(2.61%↑ Y/Y)
Prepaid expenses and
deposits
$10,531K
(60.09%↑ Y/Y)
Other current assets
$1,381K
(107.67%↑ Y/Y)
Total current assets
$541,324K
(32.36%↑ Y/Y)
Deferred tax assets, net
$178,935K
Finance right-of-use
lease assets
$65,152K
(-21.69%↓ Y/Y)
Intangible assets, net
$3,378K
(-16.51%↓ Y/Y)
Property and equipment,
net
$1,862K
(-23.09%↓ Y/Y)
Operating right-of-use
lease assets
$1,518K
(-60.44%↓ Y/Y)
Other noncurrent
assets
$93K
(0.00%↑ Y/Y)
Total assets
$792,262K
(57.64%↑ Y/Y)
Total liabilities and
shareholders' equity
$792,262K
(57.64%↑ Y/Y)
Total shareholders'
equity
$614,864K
(83.38%↑ Y/Y)
Total liabilities
$177,398K
(6.06%↑ Y/Y)
Accumulated deficit
-$577,599K
(35.23%↑ Y/Y)
Accumulated other
comprehensive loss
-$977K
(-7.96%↓ Y/Y)
Common shares no par
value, unlimited...
$1,117,248K
(-0.48%↓ Y/Y)
Total current
liabilities
$99,893K
(27.63%↑ Y/Y)
Finance lease
liabilities, less current...
$43,943K
(-25.87%↓ Y/Y)
Deferred tax benefits
$23,128K
Deferred revenue, less
current portion
$7,480K
(-39.43%↓ Y/Y)
Operating lease
liabilities, less current...
$2,009K
(-62.34%↓ Y/Y)
Other noncurrent
liabilities
$945K
Additional paid-in capital
$76,192K
(-27.67%↓ Y/Y)
Accrued expenses
$64,112K
(28.99%↑ Y/Y)
Finance lease
liabilities, current portion
$16,479K
(1.93%↑ Y/Y)
Deferred revenue
$10,593K
(92.64%↑ Y/Y)
Other current
liabilities
$5,269K
(107.69%↑ Y/Y)
Accounts payable
$1,735K
(-47.61%↓ Y/Y)
Operating lease
liabilities, current portion
$1,705K
(62.85%↑ Y/Y)
Back
Back
Balance Sheet
Aurinia Pharmaceuticals Inc. (AUPH)
Aurinia Pharmaceuticals Inc. (AUPH)
source: myfinsight.com